This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Inventor Kyle Cuneo
Introduction
Kyle Cuneo is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of radiotherapy through his innovative patents. With a total of 2 patents, Cuneo is dedicated to improving cancer treatment methodologies.
Latest Patents
Cuneo's latest patents focus on the integration of combined radiation acoustics and ultrasound for radiotherapy guidance and cancer targeting. This method and system utilize combined ultrasound and ionizing radiation induced acoustic imaging (iRAI) computed tomography imaging techniques. These techniques are capable of measuring low to ultrahigh dose deliveries exceeding 40 Gy/s. The use of multiplexed transducers allows for the detection of both ultrasound and iRAI signals, facilitating anatomical and functional imaging as well as radiation mapping. This innovation provides absolute dosimetry measurements of a region of interest during a radiotherapy session. Corrections to radiation dosage intensities and locations are determined and provided as feedback to a radiation source. This process enhances the accuracy of applied radiation dosages during treatment sessions, preventing the irradiation of healthy tissues and ensuring precise delivery of radiation to tumors or regions of interest.
Career Highlights
Kyle Cuneo is affiliated with the University of Michigan, where he continues to advance his research and innovations in the field of radiotherapy. His work is pivotal in enhancing the effectiveness of cancer treatments through technological advancements.
Collaborations
Cuneo collaborates with notable colleagues, including Ibrahim Oraiqat and Jean Moran, who contribute to his research efforts and innovations.
Conclusion
Kyle Cuneo's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving cancer treatment. His work at the University of Michigan and collaborations with esteemed colleagues further highlight his impact in the field.